Greetings!


SoCalBio Mast
SoCalBio Weekly Update

Past Weekly Updates

SoCalBio Partners

 

 

 

 

 

dwt

 

 

Los Angeles/Orange County Biotechnology Center 

SoCalBio Mast  

reedsmith  

   

SoCalBio Sponsored

EMBC2012

EMBC2012

SoCalBio members receive $200 discount per person on admission to the BioPharm America 2012. Click here to RSVP
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Media Partners
June 7, 2012




Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

[email protected]

www.socalbio.org

RSVP Now

Friday, June 8 -- 8AM - 4PM

@ Saban Research Institute in Los Angeles

2012 SoCalBio Workshop on Accessing Government Grant Funding

 

sbirworkshopThis workshop is a must-attend for first-timers and experts. It is designed to provide information about changes in the SBIR/STTR rules after the re-authiorization of the SBIR Program early this year. Speakers will share updates about funding opportunities for device and biotech companies from the NIH, DoD and other governmental institutions offering grants to bioscience companies. This event will also help you sharpen your grant-writing skills and get tips on how to leverage SBIR/STTR grant funding .... Click here for more info and to Attend

See Full SoCalBio Calendar of Events Open to the Public at: http://socalbio.org/calendar/calendar.htm
Vox Populi

Are You FOR or AGAINST Labeling

Genetically Modified Food

 

When Californians go to the polls in November, they will very likely have the chance to vote on a proposition that requires labeling of genetically modified food. If passes this proposition would make California the first state in the US enforcing such labeling requirement. Click here for a commentary by NPR on this initiative. 

 

Your Opinion Matters to SoCalBio

Are you for or against labeling GM food?

Click here to vote 

(voting is anonymous)

New SoCalBio Members
integrityBioIntegrity Bio, Inc. (Camarillo)

 

Integrity Bio, Inc. provides formulation development, process development, and contract manufacturing services for biotechnology, pharmaceutical, and medical device companies in the United States and internationally. It offers contract manufacturing services, including aseptic filling and capping of parenteral products for stability, preclinical, and clinical studies, as well as facilities to manufacture sterile lyophilized formulations. ... Learn more 

PureLyse
Claremont BioSolutions (Upland)
 
BioSolutions (ClaremontBio) is dedicated to next-generation devices for lysis and nucleic acid extraction from microbial cells for PCR ready sample. Key focuses on ClaremontBio's novel technology are ease of use, disposibility, cost effectiveness, versatility, elimination of extensive protocols, as well as elimination of the need for additional lab equipment such as centrifuges and wash baths.This novel technology can be applied to point-of-care systems, mini flow through platforms and various other integrations ... Learn more

One3 IP Management (Newbury Park)

One3 IP is dedicated to intellectual property management. The company is represented in SoCalBio by its CEO Peter Weinstein [email protected]
Coming in September

golf

Leadership

SoCalBio Adds Two Bioscience Women

to its Board of Directors

 

During its quarterly meeting on Thursday, May 24 at the Los Angeles Chamber of Commerce, members of the SoCalBio Board of Directors unanimously elected Jennifer Neff, PhD, CEO of the Orange County-based Allvivo Vascular and Denise (Dee Dee) DeMan, Chairman & CEO of the Beverly Hills-based Bench International to the Board. 

 

jneffJennifer (photo right) has a PhD degree in Bioengineering from the University of Utah. After serving as a PostDoc Fellow at the Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, she was recruited in 2000 to serve as Medical Director of Allvivo, Inc., the predecessor to Allvivo Vascular. In 2005, she became the Chief Technology Officer of Allvivo after its restructuring as Allvivo Vascular. In 2008, Jennifer took the helm at the company as a CEO .. Read more about Allvivo Vascular

 

deedeeDee Dee (photo right) has taken Bench from its founding in 1974 to its eminence today as one of the most successful specialized retained executive search firms in the world. "Dee Dee" is deeply committed to properly "shattering" the glass ceiling for women in the life sciences ... Read more

 

Click here for full list of SoCalBio Board Members

BioGENEius Competition

Congratulations to the SoCalBio Nominees to the BioGENEius Challenge Award

bioGENEius  

SoCalBio is pleased  to announce the following Southern California nominees for the BioGENEius Challenge Award:

  • Kenneth Lee, a 12th grader at Palos Verdes Peninsula High School (Los Angeles County) whose research project is entitled: "The Role of Testosterone in Hepatocyte Apoptosis in High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease."
  •  Jiho Park, a 10th grader at University High School (Orange County) whose research project focuses on: "Modeling Molecular Dynamics Simulations of Membrane-Bound Aromatase Reveal Novel Druggable Sites."

Read Press Release

 rady banner
California Tobacco Tax

Why Did Proposition 29 Fail in the Ballot?

 

prop29Big Tobacco's success in branding a proposed California cigarette tax as a government boondoggle sent a message that could echo in other states as votes trended toward the opposition. Through a barrage of campaign ads, the industry was able to cut support for a $1-a-pack cigarette tax backed by cycling legend Lance Armstrong from a two-thirds majority in March to a dead heat on Election Day ... Read more at Hufington Post

Device Tax

CBO Estimates the Repeal of the Device Tax May Cost $30 Billion Over Ten Years

 

devicetaxThe Congressional Budget Office believes that, if the medical device tax is repealed, the Federal budget deficit will grow by nearly $30 billion over a 10 year period. With no legislative action, the medical device tax is scheduled to go into effect in  January 2013 ... Read more  

Click on image for more info
Hepatitis B IND

Arrowhead Research Advances ARC-520 into IND-Enabling Studies for the Treatment of Hepatitis B and Provides Guidance on Development Timeline

 

prop29"The promotion of ARC-520 as a clinical candidate, so soon after acquiring the Roche RNAi assets, represents an important milestone for Arrowhead," said Dr. Chris Anzalone (photo right), President and Chief Executive Officer of Arrowhead. "This program follows in the footsteps of our clinical stage targeted delivery programs in obesity with Adipotide and in cancer with RONDELTM and further validates our commitment to ligand-mediated delivery in fields where most delivery is untargeted. We believe that targeting holds great promise in allowing delivery of currently undeliverable agents, such as many RNAs, and may also dramatically improve the balance of safety and effectiveness for many types of small molecule drugs" ... Read more
PET Imaging

Sofie Biosciences Launches ELIXYS, A New Generation of Automated Radiochemistry for Producing PET Imaging Probes

 

sofiebio "Fundamentally, ELIXYS is a different way to approach radiochemistry," said Patrick Phelps, Sofie's President and CEO. "ELIXYS was born out of our own need to develop and synthesize diverse classes of probes. Sofie, with our collaborators at UCLA and Caltech, are excited to share this novel technology platform with a large community of scientists and clinicians interested in expanding the diversity of PET probes to answer a vast array of biological questions" ... Read more
Collaboration

KYTHERA Biopharmaceuticals Receives $33.3M in Payments from Bayer

 

kytheraThe payments were triggered by Bayer's decision to pursue continued development and regulatory approvals for Kythera's ATX-101 after receipt of positive results from pivotal European Phase III clinical trials. ATX-101 has exhibited significant, meaningful and durable results in the reduction of submental fat, which commonly presents undesirable "double chin." These results correspond with patient satisfaction measures demonstrating meaningful improvement in perceived chin appearance... Read more

Brain Cancer Vaccine

ImmunoCellular Therapeutics Is Cited Among Developers of Novel Drugs Seeking to Cure the Cancer That Killed Ted Kennedy

 

braincancerSenator Edward Kennedy was diagnosed with brain cancer in 2008 and died 15 months later, close to the median survival time for the disease. Now, researchers at two California-based biotechnology companies, ImmunoCellular Therapeutics Ltd. (IMUC) and Tocagen Inc., along with the MD Anderson Cancer Center in Houston, are leading an effort to create drugs and treatments to fight the form of cancer that killed Kennedy, known as glioblastoma multiforme. No other brain cancer is as deadly nor spreads so quickly and the new therapies hold out the promise of more than doubling life expectancy for those who suffer from it .. Read article at Bloomberg

SoCalBio Membership Saves You Money

Become a SoCalBio Member and save money through utlizing the SoCalBio Group Purchasing Program


Video Recap of SoCalBio Open House

Jobs Available
Sofie Biosciences (Culver City)
Neumedicines (Pasadena)
Omnica (Irvine)
Xencor (Monrovia)
PBS Biotech (Camarillo)
Allvivo Vascular (Lake Forest)
Puma Biotechnology (Los Angeles)
Maven Biotechnologies (Monrovia)
Avita Medical (Northridge)
Inogen (Goleta)
Agensys (Santa Monica) 
Amgen (Thousand Oaks)
  • Amgen has 150 job openings in Thousand Oaks in research, marketing, information technology, quality, regulatory affairs and HR. Click here to access list
 Spectrum Pharmaceuticals (Irvine) 
C3 Jian (Inglewood)
International Medication Systems (South El Monte)

 

Company accepts resumes and applications for the following positions:

  • Clinical Research Professionals
  • Accounting Professionals
  • Computer (Software & Hardware) Expert/Technician
  • In-vivo Laboratory Technician
  • Mechanical/Electrical/Chemical Engineer
  • Microbiologist/Microbiology Technician
  • Product Development Analyst
  • Product Compliance Analyst
  • Quality Assurance Specialist
  • Quality Control Chemist/Technician
  • Regulatory Affairs Specialist
  • Research and Development Scientist
  • Marketing/Sales Representative
  • Technical Writer
  • Validation Engineer/Technician
  • Process Engineer
  • Maintenance Technician
  • Human Resource Professionals

See more information at: http://www.ims-limited.com/employment.htm. E-mail resumes to IMS at [email protected]

About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio